ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2019/04/22 | 1,410 | 1,420 | 1,372 | 1,389 | -36 | -2.5% | 1,444,600 |
| 2019/04/19 | 1,389 | 1,429 | 1,383 | 1,425 | +40 | +2.9% | 1,453,500 |
| 2019/04/18 | 1,459 | 1,469 | 1,383 | 1,385 | -59 | -4.1% | 2,085,900 |
| 2019/04/17 | 1,424 | 1,456 | 1,395 | 1,444 | +4 | +0.3% | 1,851,500 |
| 2019/04/16 | 1,446 | 1,500 | 1,435 | 1,440 | -19 | -1.3% | 1,939,100 |
| 2019/04/15 | 1,429 | 1,485 | 1,415 | 1,459 | +30 | +2.1% | 1,856,000 |
| 2019/04/12 | 1,528 | 1,537 | 1,422 | 1,429 | -99 | -6.5% | 3,138,600 |
| 2019/04/11 | 1,631 | 1,634 | 1,400 | 1,528 | -103 | -6.3% | 5,220,800 |
| 2019/04/10 | 1,620 | 1,654 | 1,612 | 1,631 | -19 | -1.2% | 1,784,600 |
| 2019/04/09 | 1,670 | 1,717 | 1,604 | 1,650 | +13 | +0.8% | 4,138,100 |
| 2019/04/08 | 1,615 | 1,654 | 1,597 | 1,637 | +44 | +2.8% | 3,169,000 |
| 2019/04/05 | 1,501 | 1,608 | 1,501 | 1,593 | +71 | +4.7% | 3,638,000 |
| 2019/04/04 | 1,502 | 1,590 | 1,491 | 1,522 | +41 | +2.8% | 4,278,200 |
| 2019/04/03 | 1,490 | 1,542 | 1,445 | 1,481 | +15 | +1% | 2,903,900 |
| 2019/04/02 | 1,591 | 1,635 | 1,426 | 1,466 | -83 | -5.4% | 5,929,000 |
| 2019/04/01 | 1,538 | 1,683 | 1,518 | 1,549 | +44 | +2.9% | 8,841,100 |
| 2019/03/29 | 1,510 | 1,520 | 1,462 | 1,505 | -1 | -0.1% | 3,334,900 |
| 2019/03/28 | 1,436 | 1,557 | 1,420 | 1,506 | +71 | +4.9% | 5,677,600 |
| 2019/03/27 | 1,399 | 1,536 | 1,375 | 1,435 | +49 | +3.5% | 6,507,600 |
| 2019/03/26 | 1,412 | 1,432 | 1,374 | 1,386 | -6 | -0.4% | 2,234,400 |
| 2019/03/25 | 1,313 | 1,425 | 1,304 | 1,392 | +36 | +2.7% | 5,280,700 |
| 2019/03/22 | 1,407 | 1,440 | 1,325 | 1,356 | -65 | -4.6% | 6,271,100 |
| 2019/03/20 | 1,250 | 1,526 | 1,249 | 1,421 | +195 | +15.9% | 18,249,700 |
| 2019/03/19 | 1,211 | 1,227 | 1,199 | 1,226 | +12 | +1% | 826,600 |
| 2019/03/18 | 1,176 | 1,214 | 1,174 | 1,214 | +28 | +2.4% | 929,400 |
| 2019/03/15 | 1,181 | 1,202 | 1,163 | 1,186 | -4 | -0.3% | 809,100 |
| 2019/03/14 | 1,216 | 1,229 | 1,182 | 1,190 | -25 | -2.1% | 970,500 |
| 2019/03/13 | 1,207 | 1,240 | 1,168 | 1,215 | +14 | +1.2% | 1,711,100 |
| 2019/03/12 | 1,170 | 1,206 | 1,168 | 1,201 | +44 | +3.8% | 1,427,800 |
| 2019/03/11 | 1,140 | 1,161 | 1,105 | 1,157 | +22 | +1.9% | 1,138,900 |
| 2019/03/08 | 1,136 | 1,165 | 1,116 | 1,135 | -9 | -0.8% | 1,677,000 |
| 2019/03/07 | 1,231 | 1,245 | 1,136 | 1,144 | -107 | -8.6% | 3,388,200 |
| 2019/03/06 | 1,265 | 1,267 | 1,221 | 1,251 | -4 | -0.3% | 964,500 |
| 2019/03/05 | 1,234 | 1,269 | 1,220 | 1,255 | +1 | +0.1% | 1,253,400 |
| 2019/03/04 | 1,280 | 1,286 | 1,246 | 1,254 | +4 | +0.3% | 1,189,100 |
| 2019/03/01 | 1,270 | 1,278 | 1,247 | 1,250 | +7 | +0.6% | 1,447,300 |
| 2019/02/28 | 1,307 | 1,313 | 1,242 | 1,243 | -88 | -6.6% | 2,733,900 |
| 2019/02/27 | 1,215 | 1,345 | 1,212 | 1,331 | +106 | +8.7% | 4,647,300 |
| 2019/02/26 | 1,199 | 1,288 | 1,195 | 1,225 | +30 | +2.5% | 3,436,100 |
| 2019/02/25 | 1,195 | 1,229 | 1,175 | 1,195 | +7 | +0.6% | 1,715,600 |
| 2019/02/22 | 1,181 | 1,215 | 1,171 | 1,188 | -5 | -0.4% | 1,301,400 |
| 2019/02/21 | 1,200 | 1,236 | 1,186 | 1,193 | +39 | +3.4% | 2,573,100 |
| 2019/02/20 | 1,150 | 1,174 | 1,135 | 1,154 | +21 | +1.9% | 1,309,800 |
| 2019/02/19 | 1,161 | 1,190 | 1,126 | 1,133 | -30 | -2.6% | 1,627,100 |
| 2019/02/18 | 1,150 | 1,177 | 1,138 | 1,163 | +33 | +2.9% | 1,219,300 |
| 2019/02/15 | 1,126 | 1,165 | 1,110 | 1,130 | -12 | -1.1% | 1,406,400 |
| 2019/02/14 | 1,091 | 1,149 | 1,083 | 1,142 | +44 | +4% | 1,742,800 |
| 2019/02/13 | 1,140 | 1,168 | 1,077 | 1,098 | +16 | +1.5% | 2,639,600 |
| 2019/02/12 | 1,061 | 1,140 | 1,061 | 1,082 | +45 | +4.3% | 2,462,000 |
| 2019/02/08 | 1,050 | 1,066 | 1,034 | 1,037 | -37 | -3.4% | 1,234,000 |
1501～
1550
件表示中 / 5113件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 89,500円 | +20.3% | - | 0.00% | 158.69倍 | 1.18倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 148,200円 | -2.4% | -52.3% | 3.85% | 17.74倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 211,000円 | +4.1% | -3.1% | 2.75% | 18.38倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ハートシード | 346,000円 | +174.2% | - | 0.00% | - | 10.38倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| ＪＣＲファーマ | 54,800円 | +14.3% | - | 3.65% | 22.26倍 | 1.42倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
